Bruker (BRKR)Officer sold ~$80K

~$80K

Approx. value · 2,000 sh @ $39.90

128K

Holds after · shares reported

Traded

Apr 15, 2026

Filed

Apr 16, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 13, 2026InsiderOfficer sold ~$74K of BRKR shares in the open market
2. Feb 20, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On February 16, 2026, Dr. Cynthia M. Friend informed the Board of Directors (“Board”) of Bruker Corporation (the “Company”) of her decision not to stand for re-election as a Class II director when her current term expires at the Company’s 2026 Annual Meeting of Stockholders (“2026 Annual Meeting”).”
3. Mar 13, 2026InsiderOfficer sold ~$71K of BRKR shares in the open market
4. Apr 1, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 27, 2026, the Board of Directors (the “Board”) of Bruker Corporation (the “Company”) approved an increase in the number of directors to expand the size of the Board by one director to a total of twelve directors, with such additional director assigned to Class III, and appointed Thierry L. Bernard to fill the newly created vacancy on the Board, effective as of April 1, 2026.”
5. Apr 10, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 6, 2026, Bruker Corporation (the “Company”) and Falko Busse, Ph.D., an executive officer of the Company and President of the Bruker BioSpin Group (“Bruker BioSpin”), a wholly owned subsidiary of the Company, agreed that his duties as executive officer with the Company and as President of Bruker BioSpin would transition on or around May 1, 2026 and that his employment with the Company and Bruker BioSpin…”
6. Apr 15, 2026 · this disclosureInsiderOfficer sold ~$80K of BRKR shares in the open market

What came next

1. May 6, 2026Company filing · Form 8-K · ResultsReported its results
2. May 15, 2026InsiderOfficer sold ~$88K of BRKR shares in the open market
3. Jun 15, 2026InsiderOfficer sold ~$110K of BRKR shares in the open market
4. Jul 15, 2026InsiderOfficer sold ~$121K of BRKR shares in the open market
5. Aug 4, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Bruker

For Bruker, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 11 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BRKR page.

Other recent filings by Mark Munch, EXEC VP&PRES BRUKER NANO INC.

• SEC Form 4 at Bruker (BRKR)Sep 16, 2026
• SEC Form 4 at Bruker (BRKR)Aug 18, 2026
• SEC Form 4 at Bruker (BRKR)Jul 16, 2026
• SEC Form 4 at Bruker (BRKR)Jun 16, 2026
• SEC Form 4 at Bruker (BRKR)May 18, 2026

The full history of Mark Munch, EXEC VP&PRES BRUKER NANO INC. is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Bruker

• SEC Form 4Sep 16, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its BRKR page.